Zimmer Biomet will gain through a $130m deal a spine-surgery robot that may be able to compete in the emerging minimally invasive spine surgery segment. The technology will also complement Zimmer Biomet’s other recent acquisition in spine surgery devices.
Zimmer Biomet Holdings Inc. has signed a definitive agreement to acquire French robotics company Medtech SA for about $130m, the companies announced July 18.
The Medtech deal is Zimmer Biomet’s fifth acquisition of 2016. (Also see " MNA ANALYSIS: Cardio And Ortho Billion-Buck...
A Sept. 17 panel at LSX in Boston discussed how brain-computer interface devices (BCIs) work, potential applications for BCIs, partnership, the investment landscape, ethical considerations and the five to 10-year outlook for the neurotech sector.
Medtech Insight spoke with Sanjay Kakkar, Tensive CEO, about the firm’s breast tissue regeneration implant and its surgical benefits, including a reduced operation time of 74 minutes. He anticipates regulatory approval for Regenera in early 2027.
After receiving US FDA clearance and reporting first successful use at Mayo Clinic, the Silicon Valley start-up plans to partner with leading centers to transform needle-based procedures with its robotic system starting with urology, then expand into other specialties, the CEO said.
SafeHeal has secured an additional €10m for its Colovac device, bringing its total funding to €97.5m. Led by Asabys Partners, this funding offers both economic and clinical benefits, potentially reducing costs and complications associated with temporary stomas.
AdvaMed has praised CMS’ Rural Health Transformation Program, which will allocate $50 billion over five years to enhance rural healthcare. States can apply for grants by Nov. 5 to develop sustainable healthcare systems and improve patient outcomes.
The US FDA will hold a public meeting of its Digital Health Advisory Committee in November to focus on generative AI-enabled medical devices to treat mental health.
The company is undergoing major leadership changes, having appointed 30-year medtech veteran Jane Wright as chief financial officer on Sept. 12. Wright’s appointment follows Gutteridge’s own transition to CEO earlier this year.
